PMID- 38310670 OWN - NLM STAT- MEDLINE DCOM- 20240226 LR - 20240229 IS - 1872-9142 (Electronic) IS - 0161-5890 (Linking) VI - 167 DP - 2024 Mar TI - ANXA3 interference inactivates ERK/ELK1 pathway to mitigate inflammation and apoptosis in sepsis-associated acute lung injury. PG - 25-33 LID - S0161-5890(24)00014-2 [pii] LID - 10.1016/j.molimm.2024.01.006 [doi] AB - Acute lung injury (ALI) is a prevailing and deadly complication of sepsis coupled with increasing incidence and fatality rate. Annexin A3 (ANXA3) has been unraveled to be upregulated during sepsis. This study purposed to assess the role and the mechanism of ANXA3 in sepsis-induced ALI. After the construction of mouse model of sepsis, the pathological changes of mice lung tissues were estimated by H&E staining. ANXA3 expression in mice lung tissues and serum was examined. The degree of pulmonary edema and the levels of inflammatory factors in bronchoalveolar lavage fluid (BALF) were analyzed. In lipopolysaccharide (LPS)-induced mouse ALI model in vitro, CCK-8 assay measured cell viability and flow cytometry analysis detected cell apoptosis. Besides, ELISA assay detected the release of inflammatory cytokines. Western blot analyzed the expression of proteins associated with inflammation, apoptosis and extracellular-signal-regulated kinase (ERK)/ETS-like gene 1 (ELK1) signaling. Results revealed that ANXA3 was overexpressed in the lung tissues and serum of septic mice. Following the knockdown of ANXA3, sepsis-induced lung injury was alleviated, manifested as reduced lung edema, decreased inflammatory cell infiltration and inhibited cell apoptosis. Additionally, ANXA3 silence blocked ERK/ELK1 signaling both in sepsis mouse models and in vitro model of ALI induced by lipopolysaccharide (LPS). Moreover, the inhibitory effects of ANXA3 silencing on ERK/ELK1 signaling activation, the viability damage, inflammation and apoptosis in LPS-induced mouse ALI model in vitro were partially reversed by ERK activator. Collectively, depletion of ANXA3 exerted suppressive effects on the inflammation and apoptosis in sepsis-induced ALI through blocking ERK/ELK1 signaling. CI - Copyright (c) 2024 Elsevier Ltd. All rights reserved. FAU - Liang, Jifang AU - Liang J AD - Intensive Care Unit, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032, China; Intensive Care Unit, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Electronic address: dongkekeer@163.com. FAU - Zhang, Junkun AU - Zhang J AD - Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, 030032, China. FAU - Fan, Jixiu AU - Fan J AD - General Medical Department, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032, China; General Medical Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. FAU - Chen, Shuxian AU - Chen S AD - Intensive Care Unit, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032, China; Intensive Care Unit, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. FAU - Wu, Weidong AU - Wu W AD - Intensive Care Unit, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032, China; Intensive Care Unit, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Electronic address: wuweidong@sxmu.edu.cn. LA - eng PT - Journal Article DEP - 20240203 PL - England TA - Mol Immunol JT - Molecular immunology JID - 7905289 RN - EC 3.1.4.43 (Annexin A3) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - 0 (Lipopolysaccharides) RN - 0 (Elk1 protein, mouse) SB - IM MH - Animals MH - Mice MH - *Acute Lung Injury/pathology MH - Annexin A3/metabolism MH - Apoptosis MH - Disease Models, Animal MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Inflammation/pathology MH - Lipopolysaccharides/pharmacology MH - Lung/metabolism MH - *Sepsis/metabolism OTO - NOTNLM OT - ANXA3 OT - Apoptosis OT - ERK/ELK1 signaling OT - Inflammation OT - Sepsis-induced acute lung injury EDAT- 2024/02/05 00:42 MHDA- 2024/02/26 06:42 CRDT- 2024/02/04 18:01 PHST- 2023/09/04 00:00 [received] PHST- 2023/12/21 00:00 [revised] PHST- 2024/01/08 00:00 [accepted] PHST- 2024/02/26 06:42 [medline] PHST- 2024/02/05 00:42 [pubmed] PHST- 2024/02/04 18:01 [entrez] AID - S0161-5890(24)00014-2 [pii] AID - 10.1016/j.molimm.2024.01.006 [doi] PST - ppublish SO - Mol Immunol. 2024 Mar;167:25-33. doi: 10.1016/j.molimm.2024.01.006. Epub 2024 Feb 3.